Get the facts on hepatitis b

Get the Facts on Hepatitis B

June 8, 2022 | By | Clinical Research, Hepatitis B | Blog, Clinical trials, liver health, Liver research

Like many other liver diseases, hepatitis B is a “silent epidemic” because most people do not have symptoms for most of the disease progression. It is one of the most common serious liver infections globally and in the state of …

Jaundice: A Complication of NASH

Jaundice: A Complication of NASH

May 31, 2022 | By | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications

Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …

The Liver and Hepatitis C

Hepatitis C and the Liver

May 11, 2022 | By | Clinical Research, Hepatitis C | Blog, Clinical trials, Liver research, NASH

Hepatitis C is a liver infection from the hepatitis C virus (HCV). For some people, HCV causes short-term illness. However, for more than half, it becomes a long-term, chronic infection that can result in severe and life-threatening health problems. Liver …

The liver and alcohol

The Effects of Alcohol on the Liver

April 26, 2022 | By | Clinical Research, Effects of Alcohol on the Liver, Fibroscan | AFLD, Blog, Clinical trials, Fatty Liver Disease, liver health

Alcohol is one of the most widely used substances among America’s adult and teen populations, posing substantial health and safety risks. Even though most know the adverse effects of alcohol, many tend to do so without fully recognizing the health …

Hepatitis Explained

Hepatitis Explained: What You Need to Know

March 30, 2022 | By | Clinical Research, Hepatitis | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research, NAFLD, NASH

Liver health is essential to the function of the human body. It performs over 500 functions to keep the body healthy. A few examples are flushing out toxins, processing food, and maintaining healthy blood sugar levels. Hepatitis is one of …

Love your heart, love your liver

Love Your Heart, Love Your Liver.

February 14, 2022 | By | Clinical Research, Liver Health | American heart month, Blog, Clinical trials, heart-liver connection, Liver research

When we think of hearts, we think of Valentine’s Day and the exchange of cards and unique trinkets shared with our family and friends. February is also American Heart Month which creates awareness about heart disease, the number one cause …

Read more in our blog about the latest NAFLD research

The Latest Research for NAFLD!

November 29, 2021 | By | Clinical Research, NAFLD | Blog, Clinical trials, Fatty Liver Disease, liver health

In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical …

Hepatic Encephalopathy

Hepatic Encephalopathy

October 27, 2021 | By | Fibroscan, Hepatic Encephalopathy | Blog, Clinical research, Clinical trials, HE

Hepatic encephalopathy (HE) can develop when your liver can no longer remove toxic substances from your blood. The toxins build up and can travel through your body until they eventually reach your brain. This causes mental and physical symptoms of …

Catch Cirrhosis from The Start

Catch Cirrhosis from The Start

September 29, 2021 | By | Cirrhosis, Fibroscan | Blog, Clinical trials, NAFLD, NASH

Cirrhosis of the liver is a progressive disease, developing slowly over many years. If allowed to continue, the buildup of scar tissue can eventually stop liver function. Because of the gradual decline, liver cirrhosis often goes undetected and unnoticed. You …

Hispanic adults may be at risk

Liver Disease and the Hispanic Population

July 13, 2021 | By | Clinical Trials, Liver Disease | Blog, Clinical trials, NAFLD, NASH

The number of U.S. adults with non-alcoholic fatty liver disease (NAFLD) currently sits around 25%. Approximately 2-3% of them will go on to develop non-alcoholic steatohepatitis (NASH). NASH is a more severe form of NAFLD and can lead to fibrosis, …